We have said it on many occasions, the Apple Watch is probably the most interesting device of those launched by Apple last year 2018. An Apple Watch Series 4 that arrived slightly renewing its design and that brought us some interesting new sensors such as those capable of performing electrocardiograms directly on our Apple Watch Series 4.
Apple wants to continue improving its new Apple Watch Series 4, and above all they want all the data collected thanks to its monitoring to be useful to us. The new: Apple would have signed an alliance with the Johnson & Johnson guys for improve detection of possible atrial fibrillation. After the jump we give you all the details of this important alliance ...
Johnson & Johnson is a multinational focused on health, a company that has participated in great research with the goal of improving our lives. What's new is that Apple would have teamed up with the Johnson & Johnson guys to get to know the Impact of Apple Watch Series 4's New ECG (Electrocardiogram) on Diagnosing Atrial Fibrillation. This is something quite important since Apple seeks with this alliance to know how to improve the data collection that the Apple Watch does when performing an electrocardiogram.
We have one very important source of data on our wrist and obviously you have to know how to use it. In Spain we do not yet have this new electrocardiogram available (the Johnson & Johnson alliance is focused on the US market) but it will surely end up arriving in the next few months, let us remember that the Cupertino guys have to have an authorization from the European Union to launch it in any EU country. You know, we will keep you informed of any news regarding the guys from Cupertino regarding the Apple Watch Series 4 and its launch at the European level, stay tuned ...
